The Economic Times Healthcare and Biotech News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Beat Diabetes With Lifestyle Modification
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 11, 2024 Category: Pharmaceuticals Source Type: news

Diabetes, not a death sentence: These lifestyle modifications can help you live well
The dreaded ‘D’ word—diabetes—no longer carries the same weight as a life sentence. While traditional diabetes management relied solely on medications, there’s a growing emphasis on the pivotal role lifestyle changes can play in supporting and enhancing the well-being of individuals suffering from diabetes. In the second installment of the USV diabetes awareness multimedia series, titled ‘Beat Diabetes With Lifestyle Modification’, some of India’s leading endocrinologists convened to impart savvy and sustainable strategies for embracing transformative lifestyle shifts. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 11, 2024 Category: Pharmaceuticals Source Type: news

India could see drug shortages, price rise owing to new rule: Industry executives
A recent notification by the health ministry covers the revised Schedule M rules for good manufacturing practices and requirements of premises, plant and equipment for pharmaceutical products, with provisions for an annual product quality review as well as quality risk management and a pharmaceutical quality system. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 10, 2024 Category: Pharmaceuticals Source Type: news

Ozone Pharmaceuticals eyes Rs 1,000 crore topline in next 3 years
According to the statement, Ozone launched its Molecule initiative with a vision to become the world's foremost pain management company. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 10, 2024 Category: Pharmaceuticals Source Type: news

India to demand faster inspection of pharma firms by USFDA; raise export regulations at TPF on Friday
The Indian side will also raise the issue of reinstating the Generalized System of Preferences (GSP) status to India, the official said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 10, 2024 Category: Pharmaceuticals Source Type: news

Akumentis Healthcare launches drug for treatment of epilepsy
"We understand the immense physical and emotional toll that frequent seizures can have on patients and their families," Akumentis Executive Director Kanishk Jain said. This is the driving force behind our commitment to developing novel solutions that effectively relieves the complexities of these disorders, he added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 10, 2024 Category: Pharmaceuticals Source Type: news

Lupin introduces generic product in US market
Drug firm Lupin on Wednesday said it has launched a product, used as an aid to smoking cessation treatment, in the US market. The company has launched Varenicline tablets in strengths of 0.5 mg and 1 mg, after having received approval from the US Food and Drug Administration (USFDA), the Mumbai-based drug maker said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 10, 2024 Category: Pharmaceuticals Source Type: news

Indian pharma market grows over 9 per cent in December
Among the top therapies, cardiac, anti-infectives and neuro/central nervous system have shown a relatively stronger volume growth last month, according to data from research firm PharmaTrac. Antibiotic drug Augmentin and anti-diabetes Glycomet GP continued to be the top-selling medicine brands. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 9, 2024 Category: Pharmaceuticals Source Type: news

Dr Reddy's recalls over 8,000 bottles of generic drug in US due to packaging error
Dr Reddy's Laboratories is recalling over 8,000 bottles of Tacrolimus capsules from the US market due to a packaging error. The Hyderabad-based drug major has already recalled 4,000 bottles of the same medication in March 2023. The recall is a Class II recall, initiated on December 15, 2023, due to potential adverse health consequences or a low probability of serious adverse health effects. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 7, 2024 Category: Pharmaceuticals Source Type: news

Government orders new drug-making standards after overseas deaths
The Indian government has issued a notification requiring pharmaceutical companies to adhere to new manufacturing standards in response to concerns over the quality and safety of drugs. The move comes in the wake of overseas deaths linked to Indian-made drugs since 2022, prompting increased scrutiny of the $50 billion pharmaceutical industry. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 6, 2024 Category: Pharmaceuticals Source Type: news

Quadria in talks to buy into dialysis chain NephroPlus
Quadria Capital, an Asia-focused private equity fund, is in talks to acquire a significant minority stake in India's largest dialysis chain, NephroPlus, valued at ₹2,000 crore ($250 million). Existing investors, Bessemer Venture Partners and International Finance Corporation, will exit by selling a 30% stake together, while Investcorp is likely to sell a small stake. NephroPlus, founded in 2009, operates 300+ dialysis centres in over 180 cities across four countries. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 4, 2024 Category: Pharmaceuticals Source Type: news

India is emerging as world leader in biotechnology: Union Minister Jitendra Singh
Union Minister Jitendra Singh has claimed that the biotech ecosystem in the country is emerging at a rapid pace with more than 6,500 startups and 75 bio-incubators set up by the Department of Biotechnology (DBT) - Biotechnology Industry Research Assistance Council (BIRAC). Singh said India's collective efforts and advancements in the biotechnology sector underscore the nation's potential as a global player in the field. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 4, 2024 Category: Pharmaceuticals Source Type: news

Pharma Sector: ICRA expects 9-11% growth in FY24 led by new launches, US rebound
Credit rating agency ICRA predicts that the revenues of 25 Indian pharmaceutical companies, which account for 60% of the Indian pharmaceutical industry's total revenues, will expand by 9-11% in FY24, compared to 10% in the previous year. The operating profit margin (OPM) is projected to improve to 22-23% in FY24, compared to 20.7% in FY2023. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 4, 2024 Category: Pharmaceuticals Source Type: news

Central procurement agency orders 350 million Nirodh condoms after negotiations held last month
The Central Medical Services Society (CMSS) in India has awarded tenders for 350 million condoms, despite delays in procurement. The agency failed to procure condoms in a timely manner, affecting the country's family planning programme. The All India Condom Manufacturer Association, which includes companies manufacturing condom brand Nirodh, had criticized CMSS's handling of procurement, having cancelled two condom tenders twice in 2023. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 3, 2024 Category: Pharmaceuticals Source Type: news

Dr Reddy's acquires MenoLabs' women health brands in US
Dr. Reddy’s acquired the entire MenoLabs supplements portfolio which includes seven branded products to treat perimenopause and menopause. The deal also includes the MenoLife health tracker app which supports the product line and provides community, education, and information to consumers regarding menopause. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 3, 2024 Category: Pharmaceuticals Source Type: news